CJC-1295 / Ipamorelin

CJC-1295/Ipamorelin Blend

CJC-1295/Ipamorelin Blend is a two-component research material combining a GHRH analog (CJC-1295 without DAC / Modified GRF 1-29) with ipamorelin, a ghrelin-receptor (GHS-R1a) agonist. This listing is for laboratory research use only. It is not a drug, food, cosmetic, or dietary supplement, and it is not approved for human or veterinary use.

Research Context

The two ligands appear separately in the scientific literature on complementary GH-secretagogue pathways. This listing is the laboratory combination of those peptides. This page does not describe administration, dosing, or personal use.

Research Overview

Published work has examined concurrent GHRH- and ghrelin-receptor signaling in GH-axis experimental systems. Findings from those models are not established as safe or effective for people or animals, and nothing here is medical advice.

Key Research Focus Areas

• Dual-ligand GH-axis design (GHRH analog + ghrelin-receptor agonist)
• Pituitary GH-secretion models under combined secretagogue exposure
• Comparative pharmacology of complementary GH-releasing pathways
• Analytical identity of a two-component research blend

Important Disclaimer

For research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not medical advice. Handle only in a qualified research setting and in compliance with applicable law.